SERALON non-absorbable blue (4/0) DS-15 needle 75 CM box of 24 sutures - Serag & Wiessner (VO153413) - Delynov

What is SERALON non-absorbable blue (4/0)?

SERALON by the brand Serag-Wiessner is a synthetic non-absorbable suture designed in polyamide. It comes in the form of a monofilament thread, which gives it a smooth surface reducing the wicking effect and the risks of infection compared to braided threads. This suture material complies with the European Pharmacopoeia monograph for sterile non-absorbable sutures. Its blue color, obtained by color index no. 74160 (phthalocyanine blue), allows for excellent visibility in the surgical field. This Class IIb medical device, marked CE1014, is packaged in boxes of 24 units to meet the needs of oral surgery practices.

What are the clinical indications in surgery?

SERALON is indicated for general surgical suturing. In odontological and implant practice, this nylon suture thread is particularly valued for closing mucosal incisions and stabilizing full-thickness or partial-thickness flaps. Its non-absorbable nature and monofilament structure limit the accumulation of dental plaque at the suture sites, thus promoting healthy healing of the soft tissues. The 4/0 calibre is a versatile standard for many oral surgery interventions, offering a balance between tensile strength and handling finesse for the practitioner.

What are the technical characteristics of the DS-15 needle?

The DS-15 needle equipped on this Serag-Wiessner suture has specific properties for dental surgery. The code 'DS' means it is a 3/8 circle needle with a reverse cutting triangular point. This geometry is ideal for passing through dense or keratinized tissues without causing unwanted tissue tearing, as the cutting base is oriented towards the outside of the curvature. The number 15 indicates a needle length of 15 mm, a dimension adapted to the restricted spaces of the oral cavity. The associated thread has a length of 75cm, offering ease of movement when performing surgical knots.

What are the contraindications for the use of this polyamide suture?

According to data from the manufacturer Serag-Wiessner GmbH & Co. KG, the use of SERALON is strictly contraindicated in direct contact with the heart, the central nervous system, or the central circulatory system. Furthermore, this device must not be used in patients with a known allergy to polyamide or the dyes used. It is also specified that due to a risk of progressive loss of tensile strength in the body over the long term, this material must not be used when prolonged and permanent stability of the suture is essential.

What are the precautions related to the non-absorbable nature of the thread?

As SERALON is a non-absorbable suture, it requires a subsequent intervention for the removal of stitches, generally after the initial healing phase. Due to the high elasticity characteristic of polyamide monofilament threads, the manufacturer recommends making one or two additional knots compared to braided threads to guarantee the security and strength of the suture. Particular attention must be paid during prolonged contact with saline solutions (such as in the biliary or urinary tracts), because like any foreign body, the thread can promote the formation of calculi. In ophthalmic surgery, specific warnings also apply.

Who is the manufacturer and what standards are respected?

SERALON (reference VO153413) is manufactured by Serag-Wiessner GmbH & Co. KG, a recognized manufacturer based in Germany. This medical device meets the strict regulatory requirements of Class IIb and bears the CE1014 marking. Production complies with European Pharmacopoeia (EP) standards for non-absorbable threads. Each box contains 24 sterile sutures, ensuring maximum traceability and safety for surgical procedures. Choosing this material ensures practitioners the use of a certified product, developed by a historical expert in surgical suture devices.

State of the art

Modern synthetic sutures - absorbable or non-absorbable - are central to wound healing in oral surgery. Recent advances focus on reducing post-operative infections.